Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omission of Adjuvant Radiotherapy in Young Patients With Low-Risk DCIS
NCT07762924Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Sep 2026
- Primary completion
- Feb 2032
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in ductal carcinoma in situ (DCIS), sponsored by Fudan University. Primary endpoint: Ipsilateral Breast Tumor Recurrence at 5 years. Started Sep 2026; status: recruiting.
02
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT07762924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07762924.